Dynavax Technologies Corp (DVAX)
11.35
-0.08
(-0.70%)
USD |
NASDAQ |
Apr 18, 16:00
11.35
0.00 (0.00%)
After-Hours: 20:00
Dynavax Technologies Cash and Short Term Investments (Quarterly): 742.30M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 742.30M |
| September 30, 2023 | 720.42M |
| June 30, 2023 | 681.52M |
| March 31, 2023 | 651.96M |
| December 31, 2022 | 624.40M |
| September 30, 2022 | 586.49M |
| June 30, 2022 | 518.17M |
| March 31, 2022 | 503.22M |
| December 31, 2021 | 545.95M |
| September 30, 2021 | 414.16M |
| June 30, 2021 | 345.80M |
| March 31, 2021 | 232.67M |
| December 31, 2020 | 165.04M |
| September 30, 2020 | 177.16M |
| June 30, 2020 | 200.71M |
| March 31, 2020 | 129.53M |
| December 31, 2019 | 151.06M |
| September 30, 2019 | 174.95M |
| June 30, 2019 | 140.49M |
| March 31, 2019 | 183.22M |
| December 31, 2018 | 145.54M |
| September 30, 2018 | 180.22M |
| June 30, 2018 | 216.04M |
| March 31, 2018 | 250.78M |
| December 31, 2017 | 191.85M |
| Date | Value |
|---|---|
| September 30, 2017 | 191.68M |
| June 30, 2017 | 126.96M |
| March 31, 2017 | 85.36M |
| December 31, 2016 | 81.42M |
| September 30, 2016 | 109.55M |
| June 30, 2016 | 138.99M |
| March 31, 2016 | 166.85M |
| December 31, 2015 | 196.12M |
| September 30, 2015 | 220.70M |
| June 30, 2015 | 93.38M |
| March 31, 2015 | 97.59M |
| December 31, 2014 | 122.65M |
| September 30, 2014 | 130.57M |
| June 30, 2014 | 154.31M |
| March 31, 2014 | 177.68M |
| December 31, 2013 | 189.38M |
| September 30, 2013 | 76.47M |
| June 30, 2013 | 89.16M |
| March 31, 2013 | 105.37M |
| December 31, 2012 | 125.13M |
| September 30, 2012 | 148.28M |
| June 30, 2012 | 160.20M |
| March 31, 2012 | 106.88M |
| December 31, 2011 | 113.96M |
| September 30, 2011 | 53.22M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
129.53M
Minimum
Mar 2020
742.30M
Maximum
Dec 2023
405.58M
Average
414.16M
Median
Sep 2021
Cash and Short Term Investments (Quarterly) Benchmarks
| Supernus Pharmaceuticals Inc | 254.87M |
| Ligand Pharmaceuticals Inc | 170.31M |
| Pacira BioSciences Inc | 278.58M |
| Esperion Therapeutics Inc | 82.25M |
| PetIQ Inc | 116.37M |